$5.75
-0.0951-1.63%
Ult. Agg.: Oct 30, 8:47 AM
Kyverna Therapeutics (KYTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.68 | $-0.73 | $-0.84 | $-0.96 |
| Actual | $-0.63 | $-0.66 | $-0.80 | $-0.85 |
| Surprise | +7.35% | +9.59% | +4.76% | +11.5% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.69 | $-0.78 | $-0.78 | $-0.78 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 11, 2026 | $-0.63 | $-0.68 | 7.35 % |
| Q1 | May 12, 2026 | $-0.66 | $-0.73 | 9.59 % |
| Q4 | Mar 26, 2026 | $-0.80 | $-0.84 | 4.76 % |
| Q3 | Nov 12, 2025 | $-0.85 | $-0.96 | 11.5 % |